David E. I. Pyott, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 32,450 shares at $222.00 ($7.2M) on 2024-06-24, disclosed to the SEC on 2024-06-26.
Scheduled sale ($7.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $220.00 | 17,560 | $3.9M | 53.9% |
| 2 | $221.00 | 7,420 | $1.6M | 22.9% |
| 3 | $222.00 | 7,470 | $1.7M | 23.2% |
| Total | $220.69 avg | 32,450 | $7.2M | 100% |
| Filing → |
| BMRN | BUY | 2020-09-01 | $1.0M | — | Filing → |
| AVY | SELL | 2020-02-05 | $1.3M | — | Filing → |
| AVY | SELL | 2018-11-28 | $186K | — | Filing → |